Fundz

Who to call at Supernus Pharmaceuticals, and when

Fundz watches for the moments Supernus Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Supernus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Supernus Pharmaceuticals, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Supernus Pharmaceuticals Expands Partnership with MERGE for Digital Marketing.

Jun 20, 2026

Contract Type

partnership

RockvilleBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Supernus Pharmaceuticals has expanded its partnership with MERGE, which will manage the company’s full digital ecosystem and CNS portfolio. This collaboration aims to enhance marketing efforts for products like Qelbree and support patient outreach, potentially impacting investor sentiments positively.

Company Information

Company

Supernus Pharmaceuticals

Location

Rockville, Maryland, United States

About

Supernus Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The company has a significant experience in CNS and has successfully introduced more than eight widely recognized products in this therapeutic category. Their recent advancement includes ONAPGO, a subcutaneous apomorphine infusion device for treating motor fluctuations associated with Parkinson’s disease. Supernus is committed to developing novel alternatives for managing neurological conditions.

Related People

Mollie
Senior decision-maker at this company
••••••••@••••••••

See Mollie's verified email →

Safet
Likely contact at this company
••••••••@••••••••

See Safet's verified email →

Ray
Senior decision-maker at this company
••••••••@••••••••

See Ray's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Supernus Pharmaceuticals's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Supernus Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.